Elite Pharmaceuticals, Inc. has announced that it will host a conference call to discuss its financial results for the second quarter of fiscal year 2027, which ended on September 30, 2026. This call is scheduled for Friday, November 13, 2026, at 11:30 AM EDT.

The conference call will be an opportunity for the company to share insights into its performance during the quarter and outline its strategic direction moving forward. This event is significant as it reflects Elite Pharmaceuticals' commitment to transparency and communication with its stakeholders.

Background

Elite Pharmaceuticals, Inc. is a company incorporated in New Jersey, operating in the pharmaceutical preparations sector (SIC 2834). The company trades under the ticker symbol ELTP on the OTCQB exchange. As a smaller reporting company and a non-accelerated filer, Elite Pharmaceuticals is subject to specific regulatory requirements that guide its financial disclosures.

What the Filing Says

According to the recent SEC filing (accession number 0001493152-26-051105), the company issued a press release on November 10, 2026, announcing the upcoming conference call. The press release is attached as Exhibit 99.1 in the filing.

Impact

The conference call may affect various stakeholders, including investors, analysts, and competitors in the pharmaceutical preparations industry. Investors will be particularly interested in the company's financial health and future outlook, while competitors may analyze Elite's performance to gauge market trends.

What's Next

Following the conference call on November 13, 2026, further updates may be provided in subsequent filings or press releases. The filing does not specify what happens next.